Right Ventricular Function at Rest in Highlanders/Lowlanders
NCT ID: NCT03165656
Last Updated: 2019-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
173 participants
OBSERVATIONAL
2017-05-24
2017-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Right Ventricular Function During Exercise in Highlanders/Lowlanders
NCT03165032
High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)
NCT06489704
The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion
NCT05490901
Respiratory Monitoring During Right Heart
NCT03061669
Prevalence and Prognostic Relevance of Tricuspid Regurgitation in Different Heart Failure Entities
NCT04570098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High altitude pulmonary hypertension
Highlanders with high altitude pulmonary hypertension living above 2500 m.
No interventions assigned to this group
High altitude control
Healthy highlanders living above 2500 m.
No interventions assigned to this group
Low altitude control
Healthy lowlanders living below 1000 m.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy subjects (high altitude controls)
* Both genders
* Age \>16 y
* Kyrgyz ethnicity
* born, raised and currently living at \>2500 m
* healthy subjects currently living at \<1000 m (low altitude controls)
Exclusion Criteria
* Excessive erythrocytosis
* Other coexistent disorders that may interfere with the cardio-respiratory system and sleep
* Regular use of medication that affects control of breathing
* Heavy smoking
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
OTHER_GOV
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Silvia Ulrich Somaini
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Talant M Sooronbaev, MD
Role: STUDY_CHAIR
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Center for Cardiology and Internal Medicine
Bishkek, , Kyrgyzstan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gosens R, Hiemstra PS, Adcock IM, Bracke KR, Dickson RP, Hansbro PM, Krauss-Etschmann S, Smits HH, Stassen FRM, Bartel S. Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease. Eur Respir J. 2020 Aug 20;56(2):1902320. doi: 10.1183/13993003.02320-2019. Print 2020 Aug.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01-8/433A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.